Literature DB >> 32267324

Analysis of Risk Scores to Predict Mortality in Patients Undergoing Cardiac Surgery for Endocarditis.

Fernando Pivatto Júnior1, Clarissa Carmona de Azevedo Bellagamba1, Eduardo Gatti Pianca1, Fernando Schmidt Fernandes1, Maurício Butzke1, Stefano Boemler Busato1, Miguel Gus1.   

Abstract

BACKGROUND: Risk scores are available for use in daily clinical practice, but knowing which one to choose is still fraught with uncertainty.
OBJECTIVES: To assess the logistic EuroSCORE, EuroSCORE II, and the infective endocarditis (IE)-specific scores STS-IE, PALSUSE, AEPEI, EndoSCORE and RISK-E, as predictors of hospital mortality in patients undergoing cardiac surgery for active IE at a tertiary teaching hospital in Southern Brazil.
METHODS: Retrospective cohort study including all patients aged ≥ 18 years who underwent cardiac surgery for active IE at the study facility from 2007-2016. The scores were assessed by calibration evaluation (observed/expected [O/E] mortality ratio) and discrimination (area under the ROC curve [AUC]). Comparison of AUC was performed by the DeLong test. A p < 0.05 was considered statistically significant.
RESULTS: A total of 107 patients were included. Overall hospital mortality was 29.0% (95%CI: 20.4-37.6%). The best O/E mortality ratio was achieved by the PALSUSE score (1.01, 95%CI: 0.70-1.42), followed by the logistic EuroSCORE (1.3, 95%CI: 0.92-1.87). The logistic EuroSCORE had the highest discriminatory power (AUC 0.77), which was significantly superior to EuroSCORE II (p = 0.03), STS-IE (p = 0.03), PALSUSE (p = 0.03), AEPEI (p = 0.03), and RISK-E (p = 0.02).
CONCLUSIONS: Despite the availability of recent IE-specific scores, and considering the trade-off between the indexes, the logistic EuroSCORE seemed to be the best predictor of mortality risk in our cohort, taking calibration (O/E mortality ratio: 1.3) and discrimination (AUC 0.77) into account. Local validation of IE-specific scores is needed to better assess preoperative surgical risk. (Arq Bras Cardiol. 2020; 114(3):518-524).

Entities:  

Mesh:

Year:  2020        PMID: 32267324      PMCID: PMC7792725          DOI: 10.36660/abc.20190050

Source DB:  PubMed          Journal:  Arq Bras Cardiol        ISSN: 0066-782X            Impact factor:   2.000


  25 in total

1.  Risk factors and outcome in European cardiac surgery: analysis of the EuroSCORE multinational database of 19030 patients.

Authors:  F Roques; S A Nashef; P Michel; E Gauducheau; C de Vincentiis; E Baudet; J Cortina; M David; A Faichney; F Gabrielle; E Gams; A Harjula; M T Jones; P P Pintor; R Salamon; L Thulin
Journal:  Eur J Cardiothorac Surg       Date:  1999-06       Impact factor: 4.191

2.  EuroSCORE II.

Authors:  Samer A M Nashef; François Roques; Linda D Sharples; Johan Nilsson; Christopher Smith; Antony R Goldstone; Ulf Lockowandt
Journal:  Eur J Cardiothorac Surg       Date:  2012-02-29       Impact factor: 4.191

3.  Prediction of creatinine clearance from serum creatinine.

Authors:  D W Cockcroft; M H Gault
Journal:  Nephron       Date:  1976       Impact factor: 2.847

4.  OpenEpi: a web-based epidemiologic and statistical calculator for public health.

Authors:  Kevin M Sullivan; Andrew Dean; Minn Minn Soe
Journal:  Public Health Rep       Date:  2009 May-Jun       Impact factor: 2.792

5.  Early surgery versus conventional treatment for infective endocarditis.

Authors:  Duk-Hyun Kang; Yong-Jin Kim; Sung-Han Kim; Byung Joo Sun; Dae-Hee Kim; Sung-Cheol Yun; Jong-Min Song; Suk Jung Choo; Cheol-Hyun Chung; Jae-Kwan Song; Jae-Won Lee; Dae-Won Sohn
Journal:  N Engl J Med       Date:  2012-06-28       Impact factor: 91.245

Review 6.  Challenges in Infective Endocarditis.

Authors:  Thomas J Cahill; Larry M Baddour; Gilbert Habib; Bruno Hoen; Erwan Salaun; Gosta B Pettersson; Hans Joachim Schäfers; Bernard D Prendergast
Journal:  J Am Coll Cardiol       Date:  2017-01-24       Impact factor: 24.094

7.  Risk score for cardiac surgery in active left-sided infective endocarditis.

Authors:  Carmen Olmos; Isidre Vilacosta; Gilbert Habib; Luis Maroto; Cristina Fernández; Javier López; Cristina Sarriá; Erwan Salaun; Salvatore Di Stefano; Manuel Carnero; Sandrine Hubert; Carlos Ferrera; Gabriela Tirado; Afonso Freitas-Ferraz; Carmen Sáez; Javier Cobiella; Juan Bustamante-Munguira; Cristina Sánchez-Enrique; Pablo Elpidio García-Granja; Cecile Lavoute; Benjamin Obadia; David Vivas; Ángela Gutiérrez; José Alberto San Román
Journal:  Heart       Date:  2017-04-21       Impact factor: 5.994

8.  Endocarditis caused by Staphylococcus aureus: A reappraisal of the epidemiologic, clinical, and pathologic manifestations with analysis of factors determining outcome.

Authors:  Manuel L Fernández Guerrero; Julio J González López; Ana Goyenechea; Julián Fraile; Miguel de Górgolas
Journal:  Medicine (Baltimore)       Date:  2009-01       Impact factor: 1.889

9.  Summary of Recommendation Statements.

Authors: 
Journal:  Kidney Int Suppl (2011)       Date:  2013-01

10.  Mortality Predictors in the Surgical Treatment of Active Infective Endocarditis.

Authors:  Jenny Lourdes Rivas de Oliveira; Magaly Arrais Dos Santos; Renato Tambellini Arnoni; Auristela Ramos; Dorival Della Togna; Samira Kaissar Ghorayeb; Roberto Tadeu Magro Kroll; Luiz Carlos Bento de Souza
Journal:  Braz J Cardiovasc Surg       Date:  2018 Jan-Feb
View more
  3 in total

1.  Predictors of mortality and adverse events in patients with infective endocarditis: a retrospective real world study in a surgical centre.

Authors:  Valentina Scheggi; Irene Merilli; Rossella Marcucci; Stefano Del Pace; Iacopo Olivotto; Nicola Zoppetti; Nicole Ceschia; Valentina Andrei; Bruno Alterini; Pier Luigi Stefàno; Niccolò Marchionni
Journal:  BMC Cardiovasc Disord       Date:  2021-01-12       Impact factor: 2.298

2.  Infective Endocarditis: Still More Challenges Than Convictions.

Authors:  Catarina Sousa; Fausto J Pinto
Journal:  Arq Bras Cardiol       Date:  2022-05       Impact factor: 2.667

3.  Prognostic Scores for Mortality in Cardiac Surgery for Infective Endocarditis.

Authors:  Alexandre Bahia Barreiras Martins; Cristiane da Cruz Lamas
Journal:  Arq Bras Cardiol       Date:  2020 May-Jun       Impact factor: 2.000

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.